Korean J Physiol Pharmacol.  2023 Jan;27(1):61-73. 10.4196/kjpp.2023.27.1.61.

Exosome-mediated lnc-ABCA12-3 promotes proliferation and glycolysis but inhibits apoptosis by regulating the tolllike receptor 4/nuclear factor kappa-B signaling pathway in esophageal squamous cell carcinoma

Affiliations
  • 1Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, China
  • 2Department of Cardiovascular Surgery, Affiliated Hospital of Zuinyi Medical University, Zunyi, Guizhou 563003, China
  • 3The Second Department of Thoracic Surgery, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410031, China

Abstract

Esophageal squamous cell carcinoma (ESCC) is a kind of malignant tumor with high incidence and mortality in the digestive system. The aim of this study is to explore the function of lnc-ABCA12-3 in the development of ESCC and its unique mechanisms. RT-PCR was applied to detect gene transcription levels in tissues or cell lines like TE-1, EC9706, and HEEC cells. Western blot was conducted to identify protein expression levels of mitochondrial apoptosis and toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway. CCK-8 and EdU assays were carried out to measure cell proliferation, and cell apoptosis was examined by flow cytometry. ELISA was used for checking the changes in glycolysis-related indicators. Lnc-ABCA12-3 was highly expressed in ESCC tissues and cells, which preferred it to be a candidate target. The TE-1 and EC9706 cells proliferation and glycolysis were obviously inhibited with the downregulation of lnc-ABCA12-3, while apoptosis was promoted. TLR4 activator could largely reverse the apoptosis acceleration and relieved the proliferation and glycolysis suppression caused by lnc-ABCA12-3 downregulation. Moreover, the effect of lnc-ABCA12-3 on ESCC cells was actualized by activating the TLR4/NF-κB signaling pathway under the mediation of exosome. Taken together, the lnc-ABCA12-3 could promote the proliferation and glycolysis of ESCC, while repressing its apoptosis probably by regulating the TLR4/NF-κB signaling pathway under the mediation of exosome.

Keyword

Esophageal squamous cell carcinoma; Exosomes; Lnc-ABCA12-3; Toll-like receptor 4; NF-kappa B

Figure

  • Fig. 1 Lnc-ABCA12-3 was overexpressed in esophageal squamous cell carcinoma (ESCC) tissues, serum (exosomes), and cells. (A) Volcanic diagram of differential distribution of lncRNAs expression in microarray of ESCC and adjacent normal tissues. (B) The top 10 upregulation and downregulation of differentially expressed lncRNAs was showed in heat map. (C) Lnc-ABCA12-3 levels in normal and tumor tissues were measured by RT-PCR. **p < 0.01 vs. Normal tissues group. (D) Lnc-ABCA12-3 levels in serum from healthy people and ESCC patients were measured by RT-PCR. ##p < 0.01 vs. Control group. (E) Lnc-ABCA12-3 levels in serum-exosomes from healthy people and ESCC patients were detected by RT-PCR. &&p < 0.01 vs. Control group. (F) Lnc-ABCA12-3 levels in HEEC, TE-1, and EC9706 cells were assessed by RT-PCR. ^^p < 0.01 vs. HEEC group. Data were presented as mean ± SD.

  • Fig. 2 Knockdown of lnc-ABCA12-3 inhibited the proliferation and glycolysis of esophageal squamous cell carcinoma (ESCC) cells. (A) After transfection with sh-ABCA12-3, lnc-ABCA12-3 expression was measured by RT-PCR. (B) The viability of ESCC cells were assessed by CCK-8 assay. (C, D) The proliferation was detected by EdU assay. Scale bar, 20 μm. (E–G) The contents of ATP, glucose uptake, and lactic acid production were tested by the corresponding commercial kits. Data were presented as mean ± SD. **p < 0.01 vs. sh-NC group.

  • Fig. 3 Knockdown of lnc-ABCA12-3 promoted the apoptosis of esophageal squamous cell carcinoma (ESCC) cells. (A, B) ESCC cells apoptosis were measured by flow cytometry. (C, D) The expression of Bax, Bcl-2, caspase-3, cleaved caspase-3 were detected by Western blot. Data were presented as mean ± SD. **p < 0.01 vs. sh-NC group.

  • Fig. 4 Knockdown of lnc-ABCA12-3 inactivated toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway. (A, B) The expression of TLR4, IκBα, p-IκBα, NF-κB, p-NF-κB were assessed by Western blot. Data were presented as mean ± SD. **p < 0.01 vs. sh-NC group.

  • Fig. 5 Lnc-ABCA12-3 regulated proliferation, glycolysis and apoptosis via activating TLR4. (A) The viability of esophageal squamous cell carcinoma (ESCC) cells were assessed by CCK-8 assay. (B, C) The proliferation was detected by EdU assay. Scale bar, 20 μm. (D–F) The contents of ATP, glucose uptake, and lactic acid production were tested by the corresponding commercial kits. (G, H) ESCC cells apoptosis were measured by flow cytometry. Data were presented as mean ± SD. TLR4, toll-like receptor 4; LPS, lipopolysaccharide. **p < 0.01 vs. sh-NC group, ##p < 0.01 vs. sh-ABCA12-3 group.

  • Fig. 6 The effect of lnc-ABCA12-3 on mitochondrial apoptosis pathway and toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) pathway in esophageal squamous cell carcinoma (ESCC) cells treated with LPS. (A) The expression of Bax, Bcl-2, caspase-3, cleaved caspase-3 were detected by Western blot. (B) The expression of TLR4, IκBα, p-IκBα, NF-κB, p-NF-κB were assessed by Western blot. Data were presented as mean ± SD. LPS, lipopolysaccharide. **p < 0.01 vs. sh-NC group, ##p < 0.01 vs. sh-ABCA12-3 group.

  • Fig. 7 Lnc-ABCA12-3 functioned with the esophageal squamous cell carcinoma (ESCC) cells was under the mediated of exosomes. (A) After treatment with exosomes from TE-1 cells transfected with or without sh-ABCA12-3. Lnc-ABCA12-3 expression was measured by RT-PCR. (B) The viability of ESCC cells were assessed by CCK-8 assay. (C, D) The proliferation was detected by EdU assay. Scale bar, 20 μm. (E–G) The contents of ATP, glucose uptake, and lactic acid production were tested by the corresponding commercial kits. Data were presented as mean ± SD. **p < 0.01 vs. control group, ##p < 0.01 vs. TE-1-exo group, &&p < 0.01 vs. sh-NC-TE-1-exo group.

  • Fig. 8 Lnc-ABCA12-3 regulated mitochondrial apoptosis pathway and toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) pathway under the mediated of exosomes. (A) The expression of Bax, Bcl-2, caspase-3, cleaved caspase-3 were detected by Western blot. (B) The expression of TLR4, IκBα, p-IκBα, NF-κB, p-NF-κB were assessed by Western blot. Data were presented as mean ± SD. **p < 0.01 vs. control group, ##p < 0.01 vs. TE-1-exo group, &&p < 0.01 vs. sh-NC-TE-1-exo group.


Reference

1. Tang L, Zhao S, Liu W, Parchim NF, Huang J, Tang Y, Gan P, Zhong M. 2013; Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis. BMC Cancer. 13:314. DOI: 10.1186/1471-2407-13-314. PMID: 23806209. PMCID: PMC3699416. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84879457033&origin=inward.
2. Qi YJ, Chao WX, Chiu JF. 2012; An overview of esophageal squamous cell carcinoma proteomics. J Proteomics. 75:3129–3137. DOI: 10.1016/j.jprot.2012.04.025. PMID: 22564818. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84861668900&origin=inward.
3. Hirano H, Kato K. 2019; Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy. Jpn J Clin Oncol. 49:412–420. DOI: 10.1093/jjco/hyz034. PMID: 30920626. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067627904&origin=inward.
4. Zhang R, Lau LHS, Wu PIC, Yip HC, Wong SH. Lam AK, editor. 2020. Endoscopic diagnosis and treatment of esophageal squamous cell carcinoma. Esophageal squamous cell carcinoma: Methods in molecular biology. Humana;New York: p. 47–62. https://link.springer.com/protocol/10.1007/978-1-0716-0377-2_5. DOI: 10.1007/978-1-0716-0377-2_5. PMID: 32056169. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079361603&origin=inward.
5. Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. 2020; Esophageal carcinoma: towards targeted therapies. Cell Oncol (Dordr). 43:195–209. DOI: 10.1007/s13402-019-00488-2. PMID: 31848929. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85076751284&origin=inward.
6. Mathivanan S, Ji H, Simpson RJ. 2010; Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 73:1907–1920. DOI: 10.1016/j.jprot.2010.06.006. PMID: 20601276. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77956404647&origin=inward.
7. Li M, Jia J, Li S, Cui B, Huang J, Guo Z, Ma K, Wang L, Cui C. 2021; Exosomes derived from tendon stem cells promote cell proliferation and migration through the TGF β signal pathway. Biochem Biophys Res Commun. 536:88–94. DOI: 10.1016/j.bbrc.2020.12.057. PMID: 33370718. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85098153715&origin=inward.
8. Lee Y, El Andaloussi S, Wood MJ. 2012; Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 21:R125–R134. DOI: 10.1093/hmg/dds317. PMID: 22872698. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84867118648&origin=inward.
9. Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ. 2011; Amphiregulin exosomes increase cancer cell invasion. Curr Biol. 21:779–786. DOI: 10.1016/j.cub.2011.03.043. PMID: 21514161. PMCID: PMC3417320. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79955652381&origin=inward.
10. Iwanicki-Caron I, Basile P, Toure E, Antonietti M, Lecleire S, Di Fiore A, Oden-Gangloff A, Blanchard F, Lemoine F, Di Fiore F, Sabourin JC, Michel P. 2013; Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis. Am J Gastroenterol. 108:152–155. DOI: 10.1038/ajg.2012.367. PMID: 23287955. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84872040710&origin=inward.
11. Yang G, Lu X, Yuan L. 2014; LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. DOI: 10.1016/j.bbagrm.2014.08.012. PMID: 25159663. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84907500489&origin=inward.
12. Li RQ, Ren Y, Liu W, Pan W, Xu FJ, Yang M. 2017; MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors. Nanoscale. 9:2521–2530. DOI: 10.1039/C6NR09668A. PMID: 28150831. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85013175483&origin=inward.
13. Zang B, Zhao J, Chen C. 2019; LncRNA PCAT-1 promoted ESCC progression via regulating ANXA10 expression by sponging miR-508-3p. Cancer Manag Res. 11:10841–10849. DOI: 10.2147/CMAR.S233983. PMID: 31920393. PMCID: PMC6941610. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078555094&origin=inward.
14. Tang Y, Yang P, Zhu Y, Su Y. 2020; LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro. Thorac Cancer. 11:82–94. DOI: 10.1111/1759-7714.13236. PMID: 31742924. PMCID: PMC6938768. PMID: dff3726bac2d4c4d8038f766b925d4ff. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85075121104&origin=inward.
15. Yi S, Zhang W, Zhou Q, Cheng G. 2018; lncRNA XIST promotes aggressive tumor phenotype and is associated with poor prognosis in esophageal squamous cell carcinoma. Int J Clin Exp Med. 11:8317–8323. https://e-century.us/files/ijcem/11/8/ijcem0070409.pdf.
16. Zhang L, Li P, Xing C, Zhu D, Zhang J, Wang W, Jiang G. 2020. A multi-lncRNA signature for suvival prediction in esophageal squamous cell carcinoma (ESCC) patients. Research Square. [Preprint]. Available from: https://doi.org/10.21203/rs.3.rs-26795/v1. November 2022. DOI: 10.21203/rs.3.rs-26795/v1.
17. Ma J, Xiao Y, Tian B, Chen S, Zhang B, Wu J, Wu Z, Li X, Tang J, Yang D, Zhou Y, Wang H, Su M, Wang W. 2020; Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. J Cell Biochem. 121:1374–1387. DOI: 10.1002/jcb.29373. PMID: 31512786. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073792063&origin=inward.
18. Yuan B, Liu D, Liu X. 2014; Spinal cord stimulation exerts analgesia effects in chronic constriction injury rats via suppression of the TLR4/NF-κB pathway. Neurosci Lett. 581:63–68. DOI: 10.1016/j.neulet.2014.08.023. PMID: 25153517. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84906736583&origin=inward.
19. Wang B, Li J, Tian F. 2021; Downregulation of lncRNA SNHG14 attenuates osteoarthritis by inhibiting FSTL-1 mediated NLRP3 and TLR4/NF-κB pathway through miR-124-3p. Life Sci. 270:119143. DOI: 10.1016/j.lfs.2021.119143. PMID: 33539913. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100261845&origin=inward.
20. Li X, Li H, Dong X, Wang X, Zhu J, Cheng Y, Fan P. 2018; Expression of NF-κB and TLR-4 is associated with the occurrence, progression and prognosis of esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 11:5850–5859. PMID: 31949671. PMCID: PMC6963060.
21. Jiao LI, Jingjing MA, Xue HU, Dong W. Department of Gastroenterology, Renmin Hospital of Wuhan University. 2018; The study of α-hederin induces the apoptosis of esophageal carcinoma cells via the mitochondrial pathway mediated by reactive oxygen species. Chin J Diffic Complicat Cases. 017:932–935. https://xueshu.baidu.com/usercenter/paper/show?paperid=1r3c0g702w410aw0yt0u0p104u751516&site=xueshu_se&hitarticle=1.
22. Wu B, Li J, Ni H, Zhuang X, Qi Z, Chen Q, Wen Z, Shi H, Luo X, Jin B. 2018; TLR4 activation promotes the progression of experimental autoimmune myocarditis to dilated cardiomyopathy by inducing mitochondrial dynamic imbalance. Oxid Med Cell Longev. 2018:3181278. DOI: 10.1155/2018/3181278. PMID: 30046376. PMCID: PMC6038665. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85055033580&origin=inward.
23. Huang CY, Lee CH, Tu CC, Wu CH, Huang MT, Wei PL, Chang YJ. 2018; Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis. Oncotarget. 9:9425–9441. DOI: 10.18632/oncotarget.24114. PMID: 29507700. PMCID: PMC5823643. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041390521&origin=inward.
24. Madden J, Barrett C, Laffir FR, Thompson M, Galvin P, O' Riordan A. 2021; On-chip glucose detection based on glucose oxidase immobilized on a platinum-modified, gold microband electrode. Biosensors (Basel). 11:249. DOI: 10.3390/bios11080249. PMID: 34436051. PMCID: PMC8392376. PMID: 2c82941c02e144deb3d5206656d4bbe9. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85111928543&origin=inward.
25. Fisher C, Christison T, Verma M, Yang H. 2014. Rapid determination of lactose and lactulose in dairy products using high-performance anion-exchange chromatography with pulsed amperometric detection. Thermo Scientific;Sunnyvale: p. 1–7. http://www.thermoscientific.com/content/dam/tfs/ATG/CMD/cmd-documents/sci-res/posters/ms/events/AOAC-2014/PN-71295-AOAC2014-Lactose-Lactulose-Dairy-PN71295-EN.pdf.
26. Zhang X, Liang W, Liu J, Zang X, Gu J, Pan L, Shi H, Fu M, Huang Z, Zhang Y, Qian H, Jiang P, Xu W. 2018; Long non-coding RNA UFC1 promotes gastric cancer progression by regulating miR-498/Lin28b. J Exp Clin Cancer Res. 37:134. DOI: 10.1186/s13046-018-0803-6. PMID: 29970131. PMCID: PMC6029056. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049439127&origin=inward.
27. Wang L, Zhu R, Huang Z, Li H, Zhu H. 2013; Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma. Dig Dis Sci. 58:2223–2236. DOI: 10.1007/s10620-013-2745-3. PMID: 23828139. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84881481381&origin=inward.
28. Kunizaki M, Hamasaki K, Wakata K, Tobinaga S, Sumida Y, Hidaka S, Yasutake T, Miyazaki T, Matsumoto K, Yamasaki T, Sawai T, Hamamoto R, Nanashima A, Nagayasu T. 2018; Clinical value of serum p53 antibody in the diagnosis and prognosis of esophageal squamous cell carcinoma. Anticancer Res. 38:1807–1813. DOI: 10.21873/anticanres.12419. PMID: 29491120. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043437825&origin=inward.
29. Xie H, Ma H, Zhou D. 2013; Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013:136106. DOI: 10.1155/2013/136106. PMID: 23762823. PMCID: PMC3674644. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84878692521&origin=inward.
30. Ifere GO, Ananaba GA. 2009; Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression. Recent Pat DNA Gene Seq. 3:151–163. DOI: 10.2174/187221509789318360. PMID: 19891595. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=70449562559&origin=inward.
31. Zhang S, Liang Y, Wu Y, Chen X, Wang K, Li J, Guan X, Xiong G, Yang K, Bai Y. 2019; Upregulation of a novel lncRNA LINC01980 promotes tumor growth of esophageal squamous cell carcinoma. Biochem Biophys Res Commun. 513:73–80. DOI: 10.1016/j.bbrc.2019.03.012. PMID: 30935686. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064477662&origin=inward.
32. Wu Y, Hu L, Liang Y, Li J, Wang K, Chen X, Meng H, Guan X, Yang K, Bai Y. 2017; Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2. Mol Cancer. 16:150. DOI: 10.1186/s12943-017-0715-7. PMID: 28854977. PMCID: PMC5577767. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85028501375&origin=inward.
33. Kang M, Ren M, Li Y, Fu Y, Deng M, Li C. 2018; Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA. J Exp Clin Cancer Res. 37:171. DOI: 10.1186/s13046-018-0845-9. PMCID: PMC6063009. PMID: 30049286. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050655985&origin=inward.
34. Yu Y, Pang D, Li C, Gu X, Chen Y, Ou R, Wei Q, Shang H. 2022; The expression discrepancy and characteristics of long non-coding RNAs in peripheral blood leukocytes from amyotrophic lateral sclerosis patients. Mol Neurobiol. 59:3678–3689. DOI: 10.1007/s12035-022-02789-4. PMID: 35364800. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85127377431&origin=inward.
35. Zang W, Wang T, Huang J, Li M, Wang Y, Du Y, Chen X, Zhao G. 2015; Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells. Cancer Gene Ther. 22:138–144. DOI: 10.1038/cgt.2014.77. PMID: 25591808. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84927695718&origin=inward.
36. Wang L, Zhang Z, Wang H. 2021; Downregulation of lncRNA GAS5 prevents mitochondrial apoptosis and hypoxic-ischemic brain damage in neonatal rats through the microRNA-128-3p/Bax/Akt/GSK-3β axis. Neuroreport. 32:1395–1402. DOI: 10.1097/WNR.0000000000001730. PMID: 34718247. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85121388547&origin=inward.
37. Luo G, Wang M, Wu X, Tao D, Xiao X, Wang L, Min F, Zeng F, Jiang G. 2015; Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cell Physiol Biochem. 37:2209–2220. DOI: 10.1159/000438577. PMID: 26610246. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84948654427&origin=inward.
38. Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H, Jia L. 2018; LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis. Biochem Biophys Res Commun. 503:1927–1933. DOI: 10.1016/j.bbrc.2018.07.137. PMID: 30072099. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85053113010&origin=inward.
39. Yang L, Sun K, Chu J, Qu Y, Zhao X, Yin H, Ming L, Wan J, He F. 2018; Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway. Biomed Pharmacother. 106:1570–1577. DOI: 10.1016/j.biopha.2018.07.129. PMID: 30119232. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85050542732&origin=inward.
40. Lu Z, Chen Z, Li Y, Wang J, Zhang Z, Che Y, Huang J, Sun S, Mao S, Lei Y, Gao Y, He J. 2018; TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling. J Mol Med (Berl). 96:301–313. DOI: 10.1007/s00109-018-1621-1. PMID: 29379981. PMCID: PMC5859688. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85041130871&origin=inward.
41. Zu Y, Ping W, Deng T, Zhang N, Fu X, Sun W. 2017; Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression. Dis Esophagus. 30:1–8. DOI: 10.1111/dote.12466. PMID: 27061118. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84963788662&origin=inward.
42. Jiao Z, Yu A, Rong W, He X, Zen K, Shi M, Wang T. 2020; Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma. Aging (Albany NY). 12:15002–15010. DOI: 10.18632/aging.103559. PMID: 32597791. PMCID: PMC7425435. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088820693&origin=inward.
43. Wang L, Zhang J. 2020; Exosomal lncRNA AK139128 derived from hypoxic cardiomyocytes promotes apoptosis and inhibits cell proliferation in cardiac fibroblasts. Int J Nanomedicine. 15:3363–3376. DOI: 10.2147/IJN.S240660. PMID: 32494135. PMCID: PMC7229807. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084801267&origin=inward.
44. Wen L, Mao W, Xu L, Cai B, Gu L. 2022; Sesamin exerts anti-tumor activity in esophageal squamous cell carcinoma via inhibition of TRIM44 and NF-κB signaling. Chem Biol Drug Des. 99:118–125. DOI: 10.1111/cbdd.13937. PMID: 34411455. PMID: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85114338082&origin=inward.
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr